In another study assessing dietary intervention with barley β-glucans [35], authors observed that after consuming 6 g/day of barley β-glucans during 4 weeks in patients with metabolic syndrome, no significant changes were seen compared to control group at the phylum level for the whole test group, although the production of short chain fatty acids (SCFA) was significantly increased. Here, PPIB is linked to metabolic syndrome.